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Abstract
Background  and  Objective:  Curcuma  longa  (C.  Longa)  has  strong  anti-inflammatory  effect.  This  study  aims  to  examine  the  effect
of  Curcuma  longa  extract  on  Forkhead  Box  P3  (FOXP3)  mRNA  expression  in  early  pregnant  mice  with  acute  toxoplasmosis.
Materials and Methods: This study evaluated 20 early pregnant mice that were divided into 5 groups, four mice in each. Group 1-4
received injections of Toxoplasma gondii  tachyzoites. Three days later, G1 and G2 were given orally 125 and 500 mg kgG1/day of Curcuma
longa  extract, respectively. The G3 was given 60 mg kgG1/day of spiramycin (positive control) and G4 was given 0.2 mL of distilled water
(negative control). The G5 underwent no intervention at all. Blood samples were obtained serially (before and 3 days after injection of
tachyzoites, 3 and 7 days after intervention) to assess FOXP3 mRNA expression. Results: The FOXP3 mRNA expression increased
significantly in G1-G3 3 days after intervention (p<0.05), whereas, FOXP3 mRNA expression decreased significantly (p<0.05) 7 days after
intervention and there was no significant difference between these three groups. The FOXP3 mRNA expression in G4 increased
significantly 3, 6 and 10 days after tachyzoites injections, while FOXP3 mRNA expression on G5 fluctuated but considered as insignificant
(p>0.05). Conclusion: The administration of Curcuma longa  extract at a dose of 125 mg kgG1/day for 3 days effectively increased FOXP3
mRNA expression and 7 days administration resulted in decreased FOXP3 mRNA expression in early pregnant mice with acute
toxoplasmosis.
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INTRODUCTION
Toxoplasmosis is a zoonotic disease caused by the
parasite Toxoplasma gondii1. Prevalence of toxoplasmosis is
different among country. Gandahusada2 reported that the
incidence of toxoplasmosis in Indonesia is 2-63%. The latest
incidence in Indonesia, particularly in Jakarta and Surabaya
was reported as 70 and 58%, respectively3. According to
Malarvizhi4, the incidence of toxoplasmosis in pregnancy in
Asia   and   Europe  was:  Korea  (0.8%),  Vietnam  (11.2%),
Sudan  (34.2%),  New  Zealand  (33%),  Kuba  (70.9%)  and
Europe (9-67%).
Humans can be infected through oral or fecal
transmission, blood transfusion containing tachyzoites and
vertical infections from mother to fetus through placenta5.
Toxoplasmosis  becomes  important  in  obstetrics  because
acute Toxoplasma gondii (T. gondii) infection during early
pregnancy can lead to congenital abnormalities, fetal death
and abortion6.
The Forkhead box p3 (FOXP3) gene is the main regulator
of CD4+CD25+T cells (Treg cells)7. The FOXP3  gene plays an
important role in maintaining the body's immune balance,
thereby preventing cell damage due to excessive
inflammatory reactions8. Increased FOXP3 mRNA expression
may cause various diseases9. The FOXP3 mRNA expression
decreases in the presence of acute toxoplasmosis. Thus, such
decreased in FOXP3 mRNA expression causes abortion in early
pregnant mice with acute toxoplasmosis10.
Curcuma longa is rhizomatous herbaceous perennial
plant of the Ginger family. Curcumin is the major component
of C. longa11. Several studies have been done to prove the
effectiveness of Curcumin. Curcuma longa  extract has been
shown to be an anti-inflammatory agent12. Curcumin was also
prove to be anti-bacterial13, anti-paracite14, anti-cancer15 and
against body’s immune system-related-disease15.
Curcuma longa  is one of the home spices that were
found and used extensively in Asia especially in Indonesia.
Curcuma longa  were also studied and proved to be potent
anti-inflammatory, anti-microbial and anti-oxidant. Based on
this rationale, authors aim to initiate research on effectiveness
of the C. longa  extract affecting FOXP3 mRNA expression in
early  pregnant  mice  with  acute  infection  of  T.  gondii
(acute toxoplasmosis), hoping that the result will provide
additional information for further research.
MATERIALS AND METHODS
This study was conducted in Molecular Biology and
Immunology Laboratory, Faculty of Medicine, Hasanuddin
University, Makassar, Indonesia for 5 months (June,  2017  until
October, 2017). Pathogen free female Balb/c mice were
obtained from Animal Laboratory Bogor, West Java,  Indonesia.
Experimental animals were chosen according to research
guidelines for evaluating the safety and efficacy of herbal
medicines under WHO standard. Mice were handled in Animal
Laboratory, Faculty of Medicine, Hasanuddin University and
Makassar, Indonesia in specified room with adequate air flow
under standard room temperature (28±2EC). Mice were fed
with standard natural pellets and were given adequate
amount of water.
Toxoplasma  gondii  tachyzoites  strain  RH  suspension
were obtained from the Laboratory of Bogor Agriculture
Institution, West Java, Indonesia and were stored in freezer
under -20EC before usage.
This study was conducted using 20 healthy female Balb/c
mice (age 11-13 weeks, weight 16-20 g, active and have a
good appetite). The early pregnant mice were divided into five
groups  (G1-G5)  randomly,  4  mice  each  group.  The  G1-G4
were injected with 10 tachyzoites of T. gondii RH strain
intraperitoneal and G5 without infection. Three days after
injection   of   tachyzoites,   G1   and   G2   were   each   given
C.   longa   extract  125  and  500  mg  kgG1/day,  respectively,
G3  (positive  control)  was given spiramycin 60 mg kgG1/day
and G4 (negative control) was given 0.2 mL of distilled water.
Each intervention was administered orally using cannulas for
7 days. G5 underwent no intervention at all.
Blood   samples  were  taken  from  the  tail  vein  serially
(1 day before tachyzoites injection, 3 days after tachyzoites
injection, 3 and 7 days after the intervention). The FOXP3
mRNA expression was evaluated using the quantitative
Polymerase  Chain  Reaction  (qPCR)  technique.  Quantitative
PCR systems (Applied Biosystems, Foster City, CA, USA) used
Power  SYBR®  Green  PCR  Mix  (Applied  Biosystems).  The
primary FOXP3 used was FW-TTTACTCGCATGTTGCCTACTT
and RV-TCAAATTCATCTACGGTCCACACT (NM_001199347.1),
with   standards   of   GAPDH FW-CATGGCCTTCCGTGTTCCT
and     RV-GCGGACGTCAGATCCA     (M32599.1)     normality.
Anti-toxoplasma  IgG/IgM  antibody  levels  were  determined
by  ELISA  method,  using  a  qualitative  mouse  antibody  IgG
(TP-IgG) ELISA kit (Cat No: MBS 109093) and a qualitative
mouse antibody IgM (TP-IgM) ELISA kit (Cat No: MBS 9310461).
At the end of the study, the mice were sacrificed then
buried in specified places. The procedures for animal
preservation and intervention in this study follow the
procedures of the UK Animal (Scientific Procedures) Act, 1986
and associated guidelines16. This study has been approved by
the animal ethics research committee of the Faculty of
Medicine, University of Hasanuddin, Makassar, Indonesia.
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Research data were obtained, tabulated and processed by
computer using SPSS version 20 software. The data were
analyzed statistically using paired t-test and one-way ANOVA
test with significance level of p<0.05.
RESULTS
The FOXP3 gene expression before and after tachyzoites
injection are shown in Table 1.  The  FOXP3  gene  expression
3    days    after    injection    decreased    significantly    (p<0.05)
compared to uninfected group as shown in Table 2. The
FOXP3 gene expression increased significantly (p<0.05) 3 days
after    intervention    with    C.    longa    extract    at    dose    of
125 mg kgG1/day (G1), C. longa at dose of 500 mg kgG1/day
(G2) and spiramycin at dose of 60 mg kgG1/day (G3). The
increased in FOXP3 gene expression among these 3 groups
(G1, G2, G3) does not differ significantly as shown in Table 3.
FOXP3   gene   expression   decreased   significantly   (p<0.05)
7  days  after  intervention  with  C.  longa  extract  at  dose  of
125  mg  kgG1/day  (G1),  C.  longa  at dose of 500 mg kgG1/day
Table 1: FOXP3 mRNA expression before and after injection of tachyzoites and after intervention
FOXP3 mRNA expression
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Groups A B C D
G1  9.98±0.14 7.98±0.21 12.03±0.13 9.88±0.23
G2 9.96±0.14 8.07±0.17 12.12±0.32 9.87±0.13
G3 10.02±0.15 8.54±0.09 11.93±0.12 10.14±0.15
G4 10.18±0.12 8.85±0.15 7.09 ±0.15 6.12±0.14
G5 10.00±0.19 10.20±0.14 10.06 ±0.19 9.90 ±0.16
±(Standard deviation value). Early pregnant mice group (G), G1-G4 were given Toxoplasma gondii  tachyzoites injection. While G5 were not injected and G1 was given
Curcuma longa  extract 125 mg kgG1/day, G2 was given Curcuma longa  extract 500 mg kgG1/day, G3 was given spiramycin 60 mg kgG1/day, G4 was given distilled water
0.2 mL/day, G5 underwent no intervention. Time of sample collection, A: 1 day prior tachyzoites injection, B: 3 days after tachyzoites injection, C: 3 days after the
intervention and D: 7 days after the intervention
Table 2: FOXP3 gene expression dynamics before and after Curcuma longa  extract intervention and control groups
Paired differences
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
95% confidence interval of different
Group (G)/ -----------------------------------------------------
pair group Mean Std. Dev Std. error mean Lower Upper t df Sig. (2-tailed)
G1
FOXA-FOXB 1.945 0.20936 0.10468 1.61185 2.27815 18.580 3 0.000
FOXB-FOXC -4.000 0.13491 0.06745 -4.21467 -3.78533 -59.300 3 0.000
FOXB-FOXD -1.845 0.29103 0.14552 -2.30810 -1.38190 -12.679 3 0.001
FOXC-FOXD 2.155 0.36060 0.18030 1.58120 2.72880 11.952 3 0.001
G2
FOXA-FOXB 1.8725 0.08421 0.04211 1.73850 2.00650 44.471 3 0.000
FOXB-FOXC -4.0575 0.44124 0.22062 -4.75961 -3.35539 -18.391 3 0.000
FOXB-FOXD -1.8025 0.68427 0.34213 -2.89133 -0.71367 -5.268 3 0.013
FOXC-FOXD 2.2550 0.27815 0.13907 1.81240 2.69760 16.214 3 0.001
G3
FOXA-FOXB 1.4325 0.38239 0.19120 0.82403 2.04097 7.492 3 0.005
FOXB-FOXC -3.3625 0.39016 0.19508 -3.98333 -2.74167 -17.237 3 0.000
FOXB-FOXD -1.5500 0.49686 0.24843 -2.34061 -0.75939 -6.239 3 0.008
FOXC-FOXD 1.8125 0.25461 0.12730 1.40736 2.21764 14.238 3 0.001
G4
FOXA-FOXB 1.8350 0.11504 0.05752 1.65195 2.01805 31.903 3 0.000
FOXB-FOXC 1.2625 0.17652 0.08826 0.98162 1.54338 14.305 3 0.001
FOXB-FOXD 2.2275 0.40681 0.2034 1.58018 2.87482 10.951 3 0.002
FOXC-FOXD 0.9650 0.25146 0.12573 0.56487 1.36513 7.675 3 0.005
G5
FOXA-FOXB -0.0125 0.37349 0.18674 -0.60680 0.58180 -0.067 3 0.951
FOXB-FOXC 0.0175 0.15108 0.07554 -0.22290 0.25790 0.232 3 0.832
FOXB-FOXD 0.2925 0.34856 0.17428 -0.26213 0.84713 1.678 3 0.192
FOXC-FOXD 0.2750 0.41741 0.20871 -0.38920 0.93920 1.318 3 0.279
Early pregnant mice group (G), G1-G4 were given Toxoplasma gondii  tachyzoites injection.  While  G5  were  not  injected  and  G1  was  given  Curcuma  longa  extract
125 mg kgG1/day, G2 was given Curcuma longa  extract 500 mg kgG1/day, G3 was  given  spiramycin  60  mg  kgG1/day,  G4  was  given  distilled  water  0.2  mL/day,
G5 underwent no intervention. FOXA: FOXP3 gene expression 1 day before tachyzoites injection,  FOXB:  FOXP3  gene  expression  3  days  after  tachyzoites  injection,
FOXC: FOXP3 gene expression 3 days after intervention, FOXD: FOXP3 gene expression 7 days after intervention, Significant value: p<0.05, Std. Dev: Standard deviation
3
Res. J. Immunol., 11 (1): 1-6, 2018
Table 3: Paired group comparison of FOXP3 gene expression
95% confidence interval
Mean -------------------------------------
Dependent variables (I) Group (J) Group difference (I-J) Std. Error Sig. Lower bound Upper bound
FOXP3 gene expression C. longa  125 mg kgG1/day C. longa  500 mg kgG1/day -0.08750 0.16967 0.984 -0.6114 0.4364
3 days after C. longa Spiramycin 60 mg kgG1/day 0.08250 0.16967 0.987 -0.4414 0.6064
intervention Placebo 4.94750* 0.16967 0.000 4.4236 5.4714
Normal 1.86000* 0.16967 0.000 1.3361 2.3839
C. longa  500 mg kgG1/day C. longa  125 mg kgG1/day 0.08750 0.16967 0.984 -0.4364 0.6114
Spiramycin 60 mg kgG1/day 0.17000 0.16967 0.850 -0.3539 0.6939
Placebo 5.03500* 0.16967 0.000 4.5111 5.5589
Normal 1.94750* 0.16967 0.000 1.4236 2.4714
FOXP3 gene expression C. longa  125 mg kgG1/day C. longa  500 mg kgG1/day 0.01250 0.26914 1.000 -0.8186 0.8436
after 7 days C. longa Spiramycin 60 mg kgG1/day -0.26000 0.26914 0.866 -1.0911 0.5711
intervention Placebo 3.75750* 0.26914 0.000 2.9264 4.5886
Normal -0.02000 0.26914 1.000 -0.8511 0.8111
C. longa  500 mg kgG1/day C. longa  125 mg kgG1/day -0.01250 0.26914 1.000 -0.8436 0.8186
Spiramycin 60 mg kgG1/day -0.27250 0.26914 0.846 -1.1036 0.5586
Placebo 3.74500* 0.26914 0.000 2.9139 4.5761
Normal -0.03250 0.26914 1.000 -0.8636 0.7986
Significant value: p<0.05, Std. Error: Standard error
(G2) and spiramycin at dose of 60 mg kgG1/day (G3). The
decreased in FOXP3 gene expression among these 3 groups
(G1, G2, G3) does not differ significantly (Table 3). The FOXP3
gene expression in G5 fluctuated insignificantly during the
experiment.
DISCUSSION
The anti-toxoplasma IgG/IgM antibody levels were
measured before and 3 days after injection of the T. gondii
tachyzoites. Anti-toxoplasma IgG/IgM antibody levels
increased significantly 3 days after the tachyzoites injection
(data not shown). In the previous study, intraperitoneal
injection of 10 T. gondii  tachyzoites in early pregnant mice
lead to remarkable increase of anti-toxoplasma  IgM antibody
level after 24 h, whereas, IgG antibody level increase
significantly after 72 h17.
In this study, FOXP3 mRNA expression decreased
significantly (p<0.05) 3 days after tachyzoites injection,
continue to decline until day 6 and day 10 in G5 (the pregnant
group, which was not given the tachyzoites injection and no
intervention). Some investigators also reported decreased
FOXP3 mRNA expression on spleen and placenta of pregnant
mice infected with T. gondii 7,18.
The FOXP3 gene's regulates CD4+CD25+ T cells (Treg cells).
Treg cells help to regulate the immunological balance19.
Decreasing FOXP3 expression is closely related to abortion20-22.
The declining FOXP3 mRNA expression during acute infection
will decrease suppressive effects of CD4+CD25+T cells on T
helper cells6, especially Th122,23. The reduction of suppressive
effect of Th cells causes increased pro-inflammatory cytokines
(e.g.,   interferon  γ,  TNF-")24.  Pro-inflammatory  action
increases when there is infection but an excessive increase in
pro-inflammatory Th1 may cause intravascular thrombosis and
cellular damage. When this happens in early pregnancy,
abortion may occur25,26.
Three   days   after   the   interventions   with   125   and
500   mg   kgG1/day   of   C.   longa   extract,   respectively   and
60 mg kgG1/day of spiramycin, the FOXP3 mRNA expression
increased significantly (p<0.05), although there was no
significant difference between these three groups (p>0.05).
Cong et al.27 reported that FOXP3 gene expression increased
after induction with curcumin. They found that FOXP3 gene
expression increased over time (6, 24 and 48 h and 7 days)
following induction with curcumin.
Curcumin, a major component of C. longa28,29, may
stimulate the FOXP3 mRNA expression12,28. Zhao et al.30
reported that curcumin has an inhibitory effect on CD4+CD25+
T-cell suppressor activity. It increases FOXP3 mRNA expression
via  the  transformation  growth  factor  $  pathway.  The
activated T cells suppress T-helper cells, so the expression of
pro-inflammatory cells, especially Th1, is not too high27,31.
Seven   days   after   the   intervention   with   125   and
500 mg kgG1/day of C. longa  extract and 60 mg kgG1/day of
spiramycin,  the  FOXP3  mRNA  expression  decreased
significantly (p<0.05), although there was no significant
difference among these three groups (p>0.05). Present results
are different from those reported by Cong et al.27, who stated
that the expression of FOXP3 gene increased periodically up
to 7 days after the curcumin intervention. Zhao et al.12
reported that administering curcumin at 200 mg kgG1/day for
7 days increased T-cell secretion.
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The result of this study provides new information about
FOXP3 gene expression dynamics on early pregnant mice with
acute toxoplasmosis that intervened with C. longa  extract.
Current research is limited with small sample size so further
research with larger sample size.
CONCLUSION
Curcuma  longa  extract  intervention  has  notable
influences on dynamics of FOXP3 mRNA expression in early
pregnant mice with acute toxoplasmosis. The administration
of C. longa  extract at a dose of 125 mg kgG1/day for 3 days
increased FOXP3 mRNA expression significantly (p<0.05) and
administration during 7 days decreased FOXP3 mRNA
expression significantly (p<0.05).
SIGNIFICANCE STATEMENT
This study was carried out on early pregnant mice with
acute toxoplasmosis with intention to prove C. longa  extract
on up-regulation of FOXP3 gene expression. The FOXP3 gene
expression is known to decrease on acute toxoplasmosis. Such
decreased in FOXP3 gene expression causes abortion in early
pregnant mice with acute toxoplasmosis. This study will help
the researchers to uncover the critical areas on the  effect  of
C.  longa  extract  to  prevent  abortion  on  early  pregnancy
with   acute   Toxoplasma   gondii   infection   by   interfering
up-regulation pathway of FOXP3 gene that haven’t explored
by many researchers. Thus, the result of this study can provide
latest information for further research.
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